NCT05280132
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
Phase: N/A
Role: Collaborator
Start: Dec 8, 2022
Completion: Jun 30, 2026